Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

MTRC released report about Med Tech and IVD health technology assessment (HTA) activity in Europe in 2019

29 Jun 2020

Health technology assessment plays a big role in the adoption of medical technologies in Europe. However, due to a large number of HTA organizations and the complexity of HTA schemes, the activity and their impact on reimbursement and funding decisions is not well understood.

We developed an overview of all non-drug HTAs in 2019 to help the industry to understand the HTA landscape, the role of individual HTA organizations, their activity in relation to the number of HTA reports and types of technologies covered.

The report is delivered in the Acrobat PDF version.

The report summarizes information about HTA activity in 12 European countries (+EUnetHTA), including 51 HTA organizations.

Data for all non-pharmaceutical published HTAs in 2019 are reported. In total, 256 reports are reported (in 2018, 337 reports were released by the same organizations).

The largest number of reports were published in England (108 reports, 42%), Sweden (34 reports, 13%) and Spain (26 reports, 10%).

All reports are classified using 31 technological groups. The most common types of technologies covered by HTA reports were in-vitro diagnostic (38 reports, 15%) and cardiovascular (25 reports, 10%) ones.

Download sample pages and request a quote here.